Giant cell tumor of bone: exploring HtrA1 as a potential predictor of recurrence - Scorecard - MDSpire

Giant cell tumor of bone: exploring HtrA1 as a potential predictor of recurrence

  • By

  • Akif Mirioglu

  • Kaan Ali Dalkir

  • Mehmet Yigit Gokmen

  • Melih Bagir

  • Kivilcim Eren Ates

  • Mehmet Ali Deveci

  • Gülfiliz Gönlüşen

  • Hilmi Serdar Ozbarlas

  • June 12, 2026

  • 0 min

Share

Clinical Scorecard: Investigating HtrA1 as a Possible Indicator of Recurrence in Giant Cell Tumor of Bone

At a Glance

CategoryDetail
Condition
Key MechanismsRemove or source the statement about RANKL and NF-κB pathway.
Target Population
Care Setting

Key Highlights

  • HtrA1_expression

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

        • R
        • e
        • m
        • o
        • v
        • e
        • u
        • n
        • s
        • u
        • p
        • p
        • o
        • r
        • t
        • e
        • d
        • c
        • l
        • a
        • i
        • m
        • o
        • r
        • p
        • r
        • o
        • v
        • i
        • d
        • e
        • a
        • s
        • o
        • u
        • r
        • c
        • e
        • .

        Patient & Prescribing Data

        Add source for treatment methods.

        Clinical Best Practices

        • practices

        Related Resources & Content

        Original Source(s)

        Giant cell tumor of bone: exploring HtrA1 as a potential predictor of recurrence

        • by Akif Mirioglu, Kaan Ali Dalkir, Mehmet Yigit Gokmen, Melih Bagir, Kivilcim Eren Ates, Mehmet Ali Deveci, Gülfiliz Gönlüşen, Hilmi Serdar Ozbarlas

        • June 12, 2026

        Related Content

        Editorial: Cancer Immunosurveillance

        Oncology Organization and Oncologist Networks Under Medicare Advantage Plans

        Primary cutaneous adenoid cystic carcinoma of the right forearm: a case report and dermoscopic features